Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25861622 |
US |
57 | 2 |
Overdose, |
||||
BARICITINIB, |
||||
| 2 | 25861697 |
EU |
1 | |
Toxic encephalopathy, Drug interaction, Overdose, |
||||
ERTAPENEM, ERTAPENEM SODIUM, TACROLIMUS, VORICONAZOLE, |
||||
| 3 | 25862100 |
US |
51 | 2 |
Overdose, |
||||
BARICITINIB, |
||||
| 4 | 25862579 |
EU |
39 | 2 |
Ovarian hyperstimulation syndrome, Weight increased, Abdominal discomfort, Dyspnoea, Product use in unapproved indication, Overdose, |
||||
GANIRELIX ACETATE, PROGESTERONE, FOLLITROPIN ALFA, CHORIOGONADOTROPIN ALFA, |
||||
| 5 | 25862797 |
CA |
||
Pulmonary embolism, Off label use, Overdose, |
||||
INFLIXIMAB-DYYB, HYDROXYCHLOROQUINE SULFATE, |
||||
| 6 | 25862936 |
EU |
||
Corneal neovascularisation, Overdose, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 7 | 25863436 |
US |
71 | 2 |
Coma, Toxicity to various agents, Pulseless electrical activity, Generalised tonic-clonic seizure, Overdose, |
||||
BACLOFEN, CLONIDINE, |
||||
| 8 | 25863517 |
JP |
36 | 2 |
Abdominal injury, Overdose, Ventricular tachycardia, Electrocardiogram QT prolonged, Tachycardia, Tachypnoea, Blood pressure decreased, Bradycardia, |
||||
RISPERIDONE, RISPERIDONE, RISPERIDONE, ESZOPICLONE, ESTAZOLAM, |
||||
| 9 | 25863577 |
EU |
44 | 2 |
Cardiogenic shock, Overdose, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MAVACAMTEN, |
||||
| 10 | 25864586 |
EU |
87 | 1 |
Erythema, Mouth injury, Overdose, Irritability, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 11 | 25864877 |
US |
25 | 2 |
Overdose, Extra dose administered, Incorrect dose administered, Wrong technique in product usage process, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 12 | 25865658 |
CN |
82 | 2 |
Delirium, Overdose, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 13 | 25865698 |
US |
2 | |
Bradycardia, Brain fog, Aphasia, Feeling abnormal, Nervousness, Overdose, |
||||
BUPIVACAINE AND MELOXICAM, BUPIVACAINE AND MELOXICAM, BUPIVACAINE, SERTRALINE HYDROCHLORIDE, LEVOTHYROXINE, FINASTERIDE, MINOXIDIL, |
||||
| 14 | 25866696 |
EU |
||
Cardiogenic shock, Overdose, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MAVACAMTEN, |
||||
| 15 | 25856444 |
US |
||
Drug ineffective for unapproved indication, Incorrect product administration duration, Overdose, |
||||
DEXLANSOPRAZOLE, |
||||
| 16 | 25856532 |
JP |
84 | 2 |
Eating disorder, Overdose, Blood creatinine decreased, Blood glucose increased, Glycosylated haemoglobin increased, C-reactive protein increased, White blood cell count increased, Urobilinogen urine increased, Urinary occult blood positive, Urine ketone body present, Protein urine present, Blood albumin decreased, Blood lactate dehydrogenase increased, Blood creatine phosphokinase decreased, Amylase decreased, Urine abnormality, Squamous cell carcinoma antigen increased, Cytokeratin 19 increased, |
||||
IVERMECTIN, IVERMECTIN, |
||||
| 17 | 25856955 |
EU |
1 | |
Overdose, Drug interaction, Confusional state, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, RITONAVIR, RITONAVIR 100 MG, |
||||
| 18 | 25856957 |
US |
15 | |
Overdose, No adverse event, |
||||
| 19 | 25857090 |
US |
||
Malaise, Feeling cold, Dizziness, Confusional state, Hypoaesthesia, Overdose, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 20 | 25857279 |
US |
||
Pulseless electrical activity, Motor dysfunction, Hypothermia, Bradycardia, Areflexia, Generalised tonic-clonic seizure, Overdose, Coma, Toxicity to various agents, Hypotension, |
||||
BACLOFEN, BACLOFEN, CLONIDINE, CLONIDINE, |
||||
| 21 | 25857571 |
US |
2 | |
Toxicity to various agents, Overdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 22 | 25857701 |
CA |
1 | 1 |
Myelosuppression, Neutropenia, Overdose, Off label use, |
||||
IRINOTECAN HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, TEMSIROLIMUS, TEMSIROLIMUS INJECTION, |
||||
| 23 | 25857932 |
EU |
||
Cardiogenic shock, Overdose, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MAVACAMTEN, |
||||
| 24 | 25858267 |
US |
2 | |
Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 25 | 25858772 |
EU |
||
Overdose, Respiratory depression, Loss of consciousness, |
||||
DIAZEPAM, DIAZEPAM, DIVALPROEX SODIUM, GABAPENTIN, GABAPENTIN, ZOLPIDEM TARTRATE, METHADONE HYDROCHLORIDE, METHADONE, ACAMPROSATE CALCIUM ENTERIC-COATED, ACAMPROSATE CALCIUM, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CAPSULES, |
||||
| 26 | 25858780 |
EU |
1 | |
Toxic encephalopathy, Drug interaction, Overdose, |
||||
ERTAPENEM, ERTAPENEM SODIUM, VORICONAZOLE, TACROLIMUS, |
||||
| 27 | 25859288 |
JP |
5 | 1 |
Overdose, Drug interaction, Altered state of consciousness, Toxicity to various agents, Nervous system disorder, Eye movement disorder, |
||||
TRIAZOLAM, LITHIUM CARBONATE, OLANZAPINE, VORTIOXETINE, VORTIOXETINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 28 | 25859564 |
PH |
2 | |
Dialysis, Overdose, |
||||
TOLVAPTAN, |
||||
| 29 | 25859842 |
EU |
19 | 1 |
Corneal neovascularisation, Photophobia, Visual acuity tests abnormal, Foreign body sensation in eyes, Astigmatism, Inappropriate schedule of product administration, Overdose, Meibomian gland dysfunction, Rosacea, Vision blurred, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 30 | 25860344 |
GB |
2 | |
Overdose, Alanine aminotransferase increased, Off label use, |
||||
CLOZAPINE, |
||||
| 31 | 25860376 |
CA |
26 | 1 |
Toxicity to various agents, Overdose, Postmortem blood drug level abnormal, Antemortem blood drug level abnormal, |
||||
VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FENTANYL, FENTANYL, FENTANYL, FENTANYL, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, NALOXONE, NALOXONE, NALOXONE, NALOXONE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, NALOXONE, NALOXONE, NALOXONE, NALOXONE, |
||||
| 32 | 25855865 |
US |
69 | 2 |
Overdose, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 33 | 25856355 |
US |
44 | 2 |
Expired product administered, Inappropriate schedule of product administration, Overdose, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 34 | 25854314 |
EU |
||
Interstitial lung disease, Overdose, Intentional product use issue, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, PACLITAXEL, |
||||
| 35 | 25855088 |
US |
65 | 2 |
Product dose omission issue, Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 36 | 25855187 |
AU |
24 | 1 |
Bradyarrhythmia, Low cardiac output syndrome, Toxicity to various agents, Mental status changes, Overdose, Drug withdrawal syndrome, Hypotension, Off label use, |
||||
BACLOFEN, BACLOFEN, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 37 | 25855211 |
US |
2 | |
Overdose, |
||||
FLUTICASONE FUROATE, |
||||
| 38 | 25855262 |
US |
||
Overdose, Incorrect route of product administration, |
||||
TUBERCULIN PURIFIED PROTEIN DERIVATIVE, |
||||
| 39 | 25855679 |
US |
1 | |
Toxic encephalopathy, Ileus paralytic, Product preparation error, Overdose, |
||||
CLONIDINE HYDROCHLORIDE, CLONIDINE, ERGOCALCIFEROL, |
||||
| 40 | 25850225 |
CA |
||
Osteoarthritis, Pneumonia, Overdose, Intentional product use issue, |
||||
RITUXIMAB, AZATHIOPRINE, DAPSONE GEL, 5%, DAPSONE, DASPONE, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PANTOPRAZOLE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 41 | 25850338 |
US |
51 | 1 |
Seizure, Product dose omission issue, Overdose, Product distribution issue, |
||||
BRIVARACETAM, BRIVARACETAM, LACOSAMIDE, |
||||
| 42 | 25850458 |
CA |
40 | 2 |
C-reactive protein abnormal, C-reactive protein increased, Confusional state, Contraindicated product administered, Drug hypersensitivity, Dyspnoea, Ill-defined disorder, Infusion related reaction, Injection site reaction, Intentional product use issue, Nausea, Onychomadesis, Onychomycosis, Overdose, Pain, Pemphigus, Pericarditis, Off label use, Product use issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Underdose, Wound, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Drug ineffective, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 43 | 25850492 |
AU |
||
Shock, Pulmonary oedema, Hypotension, Toxicity to various agents, Overdose, |
||||
AMLODIPINE, TELMISARTAN, |
||||
| 44 | 25850497 |
US |
2 | |
Drug ineffective, Overdose, No adverse event, |
||||
ALBUTEROL SULFATE, EPINEPHRINE, ADRENALINUM, AZELASTINE, MONTELUKAST, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 45 | 25850519 |
AU |
8 | 1 |
Shock, Hypotension, Toxicity to various agents, Overdose, |
||||
AMLODIPINE, |
||||
| 46 | 25850534 |
AU |
||
Colitis ischaemic, Shock, Toxicity to various agents, Overdose, Hypotension, |
||||
AMLODIPINE, |
||||
| 47 | 25850881 |
AU |
||
Colitis ischaemic, Cardioplegia, Overdose, |
||||
OLMESARTAN MEDOXOMIL, AMLODIPINE, |
||||
| 48 | 25850964 |
CA |
||
Platelet count decreased, Weight decreased, Immune thrombocytopenia, Underdose, Overdose, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CALCIUM, CANAGLIFLOZIN, COLLAGEN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METHYLPREDNISOLONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RAMIPRIL, RISEDRONATE SODIUM, ROSUVASTATIN, ROSUVASTATIN CALCIUM, INSULIN DEGLUDEC, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ERGOCALCIFEROL, VITAMIN E, DICLOFENAC, DICLOFENAC SODIUM, ACYCLOVIR, |
||||
| 49 | 25851306 |
CN |
15 | 1 |
Brain injury, Toxicity to various agents, Overdose, Unresponsive to stimuli, Respiratory arrest, Cardiotoxicity, Cardiac arrest, Electrocardiogram QT prolonged, Sinus tachycardia, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
| 50 | 25851674 |
US |
82 | 2 |
Overdose, Wrong strength, Product prescribing error, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 51 | 25851930 |
EU |
33 | 1 |
Hypoglycaemia, Arteriosclerosis coronary artery, Coronary artery occlusion, Peptic ulcer, Secondary hypogonadism, Hypertension, Chest pain, Andropause, Blood testosterone increased, Insulin-like growth factor increased, Irritable bowel syndrome, High density lipoprotein decreased, Drug abuse, Performance enhancing product use, Off label use, Hormone level abnormal, Depression, Alanine aminotransferase increased, Blood triglycerides increased, Adverse event, Overdose, Intentional product misuse, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), TESTOSTERONE, TESTOSTERONE,, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, TELMISARTAN, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, ANASTROZOLE, ANASTROZOLE TABLETS, CABERGOLINE, CABERGOLINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, SOMATROPIN, SOMATROPIN, EZETIMIBE, |
||||
| 52 | 25852100 |
US |
34 | 2 |
Overdose, |
||||
TIRZEPATIDE, |
||||
| 53 | 25852163 |
CA |
||
Discouragement, Illness, Insomnia, Lip swelling, Needle issue, Product use complaint, Pruritus, Scab, Scratch, Skin haemorrhage, Skin injury, Swelling, Swelling of eyelid, Urticaria, Injection site pain, Drug administered in wrong device, Off label use, Therapeutic response decreased, Wrong technique in product usage process, Intentional product use issue, Overdose, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, MONTELUKAST, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DOXEPIN, DOXEPIN HYDROCHLORIDE, DOXEPIN, DOXEPIN HYDROCHLORIDE, PREDNISONE, VALPROIC ACID, |
||||
| 54 | 25852662 |
JP |
20 | 2 |
Toxicity to various agents, Overdose, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DEXTROMETHORPHAN, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LORAZEPAM, |
||||
| 55 | 25852668 |
JP |
15 | 1 |
Toxicity to various agents, Overdose, False positive investigation result, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 56 | 25852669 |
JP |
14 | 2 |
Overdose, Toxicity to various agents, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 57 | 25853202 |
EU |
35 | 1 |
Death, Overdose, Completed suicide, |
||||
BUPRENORPHINE HYDROCHLORIDE, OXAZEPAM, PREGABALIN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 58 | 25853363 |
CN |
55 | 1 |
Muscle twitching, Renal failure, Incorrect dose administered, Gaze palsy, Overdose, Nystagmus, |
||||
IMIPENEM AND CILASTATIN SODIUM, IMIPENEM AND CILASTATIN, IMIPENEM AND CILASTATIN SODIUM, IMIPENEM AND CILASTATIN, |
||||
| 59 | 25853957 |
EU |
34 | 1 |
Acute kidney injury, Pyrexia, Abdominal pain, Anaemia, Overdose, Thrombocytopenia, Mucosal inflammation, Drug level increased, Hepatic cytolysis, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 60 | 25853959 |
EU |
17 | 1 |
Acute kidney injury, Anaemia, Drug level increased, Hepatic cytolysis, Overdose, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 61 | 25854172 |
US |
82 | 1 |
Product prescribing error, Incorrect dose administered, Overdose, Off label use, |
||||
NIRMATRELVIR AND RITONAVIR, NIRMATRELVIR AND RITONAVIR, |
||||
| 62 | 25854205 |
US |
91 | 1 |
Overdose, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 63 | 25854208 |
US |
68 | 1 |
Overdose, Product communication issue, Incorrect dose administered, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 64 | 25859486 |
57 | 2 | |
Overdose, Vomiting, Headache, Abdominal distension, Constipation, Product label confusion, |
||||
SEMAGLUTIDE, |
||||
| 65 | 25844136 |
JP |
7 | 2 |
Overdose, No adverse event, |
||||
VORTIOXETINE, |
||||
| 66 | 25844269 |
CA |
21 | 2 |
Syphilis, Snoring, Hypersomnia, Sedation complication, Overdose, Off label use, Maternal exposure during pregnancy, |
||||
METHADONE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 67 | 25844893 |
US |
||
Overdose, Withdrawal syndrome, |
||||
BACLOFEN INJECTION, |
||||
| 68 | 25844914 |
EU |
||
International normalised ratio increased, Overdose, Alanine aminotransferase increased, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 69 | 25845168 |
CA |
2 | |
Food allergy, Hyperhidrosis, Headache, Hepatic enzyme increased, Hypersensitivity, Hypertension, Immunodeficiency, Infusion related reaction, Joint swelling, Pain, Exposure during pregnancy, Overdose, Prescribed overdose, Product use issue, Intentional product misuse, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALBUTEROL SULFATE, QUETIAPINE FUMARATE, QUETIAPINE, SENNA LEAF, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALBUTEROL SULFATE, ALBUTEROL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BUPROPION, BUPROPION, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, PROGESTERONE, |
||||
| 70 | 25845179 |
AU |
||
Toxicity to various agents, Completed suicide, Overdose, Suicide attempt, |
||||
ALPRAZOLAM, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 71 | 25845263 |
US |
1 | |
Product dose omission issue, Overdose, Incorrect dose administered, Mental disorder, Visual impairment, |
||||
| 72 | 25845394 |
CA |
||
Abdominal discomfort, Amnesia, Asthma, Body temperature increased, Bronchial obstruction, Chest discomfort, Chest injury, Chronic obstructive pulmonary disease, Dyspnoea, Ear congestion, Ear inflammation, Fall, Flank pain, Haematochezia, Head injury, Hypertension, Hypoacusis, Hypopnoea, Irritable bowel syndrome, Limb injury, Liver function test abnormal, Lyme disease, Lymphadenopathy, Malaise, Mucous stools, Musculoskeletal chest pain, Neuropathy peripheral, Oropharyngeal pain, Osteoarthritis, Otitis media chronic, Otorrhoea, Pain, Pneumonia, Polyp, Poor quality sleep, Presyncope, Pulmonary congestion, Renal cyst, Rhinorrhoea, Rubber sensitivity, Sinus disorder, Tenderness, Sputum discoloured, Sputum increased, Tinnitus, Urinary tract infection, Viral infection, Abdominal pain, Bronchitis, Cystitis, Fungal infection, Nasopharyngitis, Wheezing, Influenza, Cough, Hypersensitivity, Dizziness, Headache, Injection site pain, Injection site swelling, Paraesthesia, Pyrexia, Incorrect dose administered, Product dose omission issue, Intentional product use issue, Overdose, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, BISOPROLOL FUMARATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MOXIFLOXACIN HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
| 73 | 25845399 |
AU |
38 | 2 |
Cardiac dysfunction, Cardiogenic shock, Electrocardiogram ST segment depression, Unresponsive to stimuli, Drug interaction, Fatigue, Hypotension, Lung opacity, Metabolic acidosis, Off label use, Overdose, Sinus tachycardia, Sputum purulent, Tachycardia, |
||||
LURASIDONE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, FOLIC ACID, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 74 | 25845540 |
EU |
10 | 1 |
Electrocardiogram QT prolonged, Vomiting, Overdose, Medication error, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 75 | 25846060 |
US |
29 | 2 |
Brain injury, Overdose, Product administration error, |
||||
FENTANYL, LEVOTHYROXINE, |
||||
| 76 | 25846316 |
CA |
40 | 2 |
Immunodeficiency, Pain, Hyperhidrosis, Exposure during pregnancy, Joint swelling, Off label use, Hypertension, Product use issue, Food allergy, Prescribed overdose, Infusion related reaction, Hepatic enzyme increased, Intentional product misuse, Overdose, Hypersensitivity, Headache, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, RITUXIMAB, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ABACAVIR AND LAMIVUDINE, ABACAVIR AND LAMIVUDINE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, SENNOSIDES, SENNOSIDES, SENNOSIDES, PROGESTERONE, PROGESTERONE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, QUETIAPINE FUMARATE, QUETIAPINE, KETOPROFEN, ABATACEPT, ABATACEPT, CLONIDINE HYDROCHLORIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, MONTELUKAST SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FLUCONAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, GABAPENTIN, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FUROSEMIDE, ETANERCEPT, TEMAZEPAM, TEMAZEPAM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PSYLLIUM HUSK, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, BUPROPION, BUPROPION, BUPROPION, BUPROPION, BUPROPION, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ASCORBIC ACID, IOPAMIDOL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ABACAVIR SULFATE, ABACAVIR SULFATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, SENNOSIDES, SENNA LEAF, SENNOSIDES A AND B, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, SENNOSIDES, SENNOSIDES, SENNOSIDES, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ASCORBIC ACID, SENNOSIDES A AND B, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, CYCLOBENZAPRINE, CYCLOBENZAPRINE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, BUPROPION, BUPROPION, BUPROPION, BUPROPION, BUPROPION, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, TEMAZEPAM, ONDANSETRON HYDROCHLORIDE, |
||||
| 77 | 25847208 |
CN |
31 | 2 |
Cushing^s syndrome, Erythrodermic psoriasis, Hypoproteinaemia, Overdose, Intentional product use issue, |
||||
CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, |
||||
| 78 | 25847303 |
US |
2 | |
Oral candidiasis, Overdose, Dyspnoea, Somnolence, Diarrhoea, Ageusia, Anosmia, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 79 | 25847753 |
CA |
2 | |
Thyroid cancer, Pharyngitis streptococcal, Injection site swelling, Injection site pain, Injection site erythema, Diarrhoea, Wrong technique in product usage process, Overdose, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LEVOTHYROXINE SODIUM, |
||||
| 80 | 25847835 |
US |
3 | 1 |
Overdose, Product prescribing issue, Myelosuppression, |
||||
HYDROXYUREA, |
||||
| 81 | 25848099 |
US |
46 | 2 |
Depression, Brain fog, Overdose, Inappropriate schedule of product administration, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 82 | 25848100 |
EG |
32 | 2 |
Hypoaesthesia, Defaecation urgency, Eyelid ptosis, Feeling cold, Overdose, Abdominal pain, Vomiting, Abdominal pain upper, Nausea, Musculoskeletal stiffness, Muscle spasms, Intentional product misuse, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 83 | 25848419 |
US |
||
Overdose, Vomiting, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 84 | 25849015 |
US |
64 | 1 |
Pallor, Overdose, |
||||
OCRELIZUMAB, |
||||
| 85 | 25838796 |
EU |
61 | 2 |
Stress cardiomyopathy, Overdose, |
||||
ZOLEDRONIC ACID, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MODAFINIL, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 86 | 25838880 |
US |
1 | |
Influenza, Pneumonia, Overdose, |
||||
ROTIGOTINE, |
||||
| 87 | 25839098 |
CA |
||
Overdose, Feeling abnormal, Gastrointestinal pain, Skin discolouration, Cerebral disorder, Diarrhoea haemorrhagic, Loss of employment, Dysarthria, Tremor, Discomfort, Flatulence, Constipation, Alopecia, Tinnitus, |
||||
| 88 | 25839487 |
US |
1 | |
Hip fracture, Visual impairment, Overdose, Fall, |
||||
RAVULIZUMAB, CALCIUM, |
||||
| 89 | 25839510 |
CA |
||
Uveitis, Diarrhoea, Harvey-Bradshaw index increased, Arthralgia, Abdominal pain, Intentional product use issue, Overdose, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, DIMENHYDRINATE, |
||||
| 90 | 25839892 |
US |
||
Overdose, |
||||
SECUKINUMAB, |
||||
| 91 | 25840060 |
US |
1 | |
Incorrect dose administered, Product dose omission issue, Overdose, Device use issue, Chronic obstructive pulmonary disease, Device delivery system issue, Wrong technique in device usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 92 | 25840328 |
EU |
70 | 1 |
Fall, Overdose, Hallucination, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 93 | 25840340 |
US |
40 | 1 |
Renal tubular necrosis, Tubulointerstitial nephritis, Overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CEPHALEXIN, CEPHALEXIN, |
||||
| 94 | 25840383 |
US |
51 | 1 |
Milk-alkali syndrome, Mental impairment, Acute kidney injury, Overdose, Hyponatraemia, Hypokalaemia, |
||||
CALCIUM CARBONATE, ANTACID, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 95 | 25840700 |
US |
18 | 2 |
Mental disorder, Toxic encephalopathy, Toxicity to various agents, Coagulopathy, Overdose, Abdominal pain, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 96 | 25841382 |
CA |
2 | |
Overdose, Cardiac flutter, |
||||
INFLIXIMAB, CYANOCOBALAMIN, |
||||
| 97 | 25841397 |
US |
29 | 1 |
Cardiogenic shock, Multiple organ dysfunction syndrome, Electrocardiogram QRS complex prolonged, Electrocardiogram QT prolonged, Cardiac dysfunction, Tachycardia, Leukocytosis, Chest pain, Hypotension, Somnolence, Nausea, Vomiting, Abdominal pain, Diarrhoea, Dizziness, Lethargy, Cyanosis, Pallor, Mucosal dryness, Overdose, |
||||
COLCHICINE, COLCHICINE, CARVEDILOL, CARVEDILOL, |
||||
| 98 | 25841466 |
EU |
21 | 2 |
Toxicity to various agents, Drug abuse, Overdose, |
||||
PREGABALIN, |
||||
| 99 | 25841493 |
EU |
61 | 2 |
Asphyxia, Visceral congestion, Pulmonary oedema, Brain oedema, Coronary artery stenosis, Myocardial haemorrhage, Pulmonary alveolar haemorrhage, Toxicity to various agents, Bezoar, Cyanosis, Cervix inflammation, Vascular calcification, Vomiting, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CEFUROXIME, IRON, ACETYLCYSTEINE, |
||||
| 100 | 25841805 |
US |
77 | 1 |
Death, Overdose, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30